Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
Community Psychiatry
•
General Psychiatry
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
Related Questions
When do you choose to switch to antidepressants vs augmentation in treatment-resistant depression?
When do you use seizure prophylaxis in patients on clozapine?
How do you approach a treatment relationship with a patient who is non-adherent to recommendations and also is not interested in transfer to another practitioner?
What are the most effective strategies for managing weight gain associated with antipsychotic medications?
Is there a benefit to augmenting treatment for schizophrenia by adding aripiprazole (a partial D2 agonist) to a full D2 antagonist such as haloperidol?
When do you consider using multiple antipsychotic medications for chronic management of psychosis?
How do you address akathisia for patients who have had otherwise an excellent response to their antipsychotic treatment?
How can clinicians safely manage the potential cardiac risks associated with low-dose amphetamines in older adults, while ensuring the treatment's benefits outweigh the risks in cases of failure-to-thrive depression?
Is there evidence to suggest there is a withdrawal syndrome from muscle relaxants such as tizanidine?
How do you counsel patients with bipolar disorder who want to breastfeed?
